Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
Work
Year: 2020
Type: article
Abstract: Rationale: Patients with refractory Mycobacterium avium complex (MAC) lung disease have limited treatment options. In the CONVERT study, amikacin liposome inhalation suspension (ALIS) added to guideli... more
Institutions Oregon Health & Science University, Medical University of South Carolina, Gallipoli Medical Research Foundation, The University of Queensland, Insmed (United States) +15 more
Cites: 30
Cited by: 45
Related to: 10
FWCI: 4.023
Citation percentile (by year/subfield): 87.74
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid